Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 74 articles:
HTML format

Single Articles

    November 2022
  1. XIA S, Zhang Y, Peng B, Hu X, et al
    Detection of mild cognitive impairment in type 2 diabetes mellitus based on machine learning using privileged information.
    Neurosci Lett. 2022;791:136908.
    PubMed     Abstract available

  2. FARHANGIAN M, Azarafrouz F, Chavoshinezhad S, Dargahi L, et al
    Intranasal interferon-beta alleviates anxiety and depressive-like behaviors by modulating microglia polarization in an Alzheimer's disease model.
    Neurosci Lett. 2022 Nov 14:136968. doi: 10.1016/j.neulet.2022.136968.
    PubMed     Abstract available

  3. FOLORUNSO OO, Harvey TL, Brown SE, Chelini G, et al
    The D-serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease.
    Neurosci Lett. 2022;792:136958.
    PubMed     Abstract available

    October 2022
  4. SHEN Q, Patten KT, Valenzuela A, Lein PJ, et al
    Probing changes in brain esterified oxylipin concentrations during the early stages of pathogenesis in Alzheimer's Disease transgenic rats.
    Neurosci Lett. 2022 Oct 18:136921. doi: 10.1016/j.neulet.2022.136921.
    PubMed     Abstract available

  5. RAFIEY M, Nosrati R, Babaei P
    Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.
    Neurosci Lett. 2022;789:136881.
    PubMed     Abstract available

    September 2022
  6. WANG Y, Lv S, Zhou X, Niu X, et al
    Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.
    Neurosci Lett. 2022;790:136892.
    PubMed     Abstract available

  7. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    PubMed     Abstract available

  8. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    PubMed     Abstract available

    August 2022
  9. LONG Y, Cheng Y, Yang J, Yang T, et al
    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23.
    Neurosci Lett. 2022;785:136771.
    PubMed     Abstract available

    July 2022
  10. RONG Y, Mi X, Ni C, Liu T, et al
    Protective effect of vitamin C on DNA damage in surgery-induced cognitive dysfunction in APP/PS1 mice.
    Neurosci Lett. 2022;784:136740.
    PubMed     Abstract available

  11. LIN J, Niu Z, Xue Y, Gao J, et al
    Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;783:136725.
    PubMed     Abstract available

  12. KOCA S, Kiris I, Sahin S, Cinar N, et al
    Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Neurosci Lett. 2022 Jul 13:136799. doi: 10.1016/j.neulet.2022.136799.
    PubMed     Abstract available

  13. ZHANG Y, Liu D, Yao X, Wen J, et al
    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
    Neurosci Lett. 2022 Jul 7:136770. doi: 10.1016/j.neulet.2022.136770.
    PubMed     Abstract available

    June 2022
  14. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    PubMed     Abstract available

  15. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.

  16. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    PubMed     Abstract available

    May 2022
  17. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    PubMed     Abstract available

    April 2022
  18. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    PubMed     Abstract available

    February 2022
  19. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    PubMed     Abstract available

  20. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    PubMed     Abstract available

  21. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    PubMed     Abstract available

    January 2022
  22. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.

  23. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    PubMed     Abstract available

  24. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    PubMed     Abstract available

    December 2021
  25. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    PubMed     Abstract available

  26. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    PubMed     Abstract available

  27. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    PubMed     Abstract available

    November 2021
  28. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    PubMed     Abstract available

  29. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    PubMed     Abstract available

  30. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    PubMed     Abstract available

    October 2021
  31. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    PubMed     Abstract available

  32. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    PubMed     Abstract available

    September 2021
  33. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    PubMed     Abstract available

  34. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    PubMed     Abstract available

  35. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    PubMed     Abstract available

  36. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available

  37. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    PubMed     Abstract available

    August 2021
  38. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    PubMed     Abstract available

  39. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    PubMed     Abstract available

  40. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    PubMed     Abstract available

  41. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    PubMed     Abstract available

    July 2021
  42. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    PubMed     Abstract available

  43. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    PubMed     Abstract available

  44. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    PubMed     Abstract available

  45. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    PubMed     Abstract available

  46. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    PubMed     Abstract available

    June 2021
  47. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    PubMed     Abstract available

  48. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    PubMed     Abstract available

  49. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available

    May 2021
  50. DAINI E, Secco V, Liao W, Zoli M, et al
    A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
    Neurosci Lett. 2021;754:135869.
    PubMed     Abstract available

  51. HE B, Wang L, Xu B, Zhang Y, et al
    Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
    Neurosci Lett. 2021;754:135765.
    PubMed     Abstract available

  52. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    PubMed     Abstract available

  53. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    PubMed     Abstract available

  54. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    PubMed     Abstract available

  55. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    PubMed     Abstract available

    April 2021
  56. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    PubMed     Abstract available

  57. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    PubMed     Abstract available

  58. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    PubMed     Abstract available

  59. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
    Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
    Neurosci Lett. 2021;749:135721.
    PubMed     Abstract available

    February 2021
  60. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
    Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
    PubMed     Abstract available

  61. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
    Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
    PubMed     Abstract available

    Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
    Neurosci Lett. 2021;746:135649.
    PubMed     Abstract available

  63. LIM KH, Kim SH, Yang S, Chun S, et al
    Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
    Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
    PubMed     Abstract available

  64. XU L, Dong Q, Xu L, Zou W, et al
    The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
    Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
    PubMed     Abstract available

    January 2021
  65. LIANG C, Mu Y, Tian H, Wang D, et al
    MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
    PubMed     Abstract available

  66. ZHANG B, Wu L, Zhu Q, Dong Y, et al
    Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
    Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
    PubMed     Abstract available

  67. WANG Y, Sheng H, Zhao J, Guo L, et al
    Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
    Neurosci Lett. 2021;741:135453.
    PubMed     Abstract available

  68. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
    Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
    Neurosci Lett. 2021;740:135447.
    PubMed     Abstract available

    December 2020
  69. WANG J, Guo MN, Liu ZZ, Ma SF, et al
    PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
    Neurosci Lett. 2020;744:135598.
    PubMed     Abstract available

  70. TIAN Z, Dong Q, Wu T, Guo J, et al
    MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
    PubMed     Abstract available

    November 2020
  71. SONG X, Chen J, Hou Z, Xie N, et al
    Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
    Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
    PubMed     Abstract available

    May 2020
  72. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available

    April 2020
  73. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    PubMed     Abstract available

    February 2020
  74. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.